生物标志物对肝衰竭合并细菌感染诊断的研究进展

摘要/Abstract

摘要： 细菌感染是肝衰竭最常见并发症之一。细菌感染可能会导致肝衰竭患者更容易发生多器官功能障碍甚至死亡。由于肝衰竭合并细菌感染患者临床表现不典型、病原微生物培养阳性率较低、周期长,其识别和诊断存在困难,故积极寻找其有效的生物标志物具有重要临床意义,这不仅有助于早期识别,还可早期启动抗感染治疗,从而改善患者预后。本文主要介绍生物标志物在诊断肝衰竭合并感染中的最新进展,旨在为该病的早期诊断提供参考依据。

王莹, 蔡大川. 生物标志物对肝衰竭合并细菌感染诊断的研究进展[J]. 肝脏, 2024, 29(1): 133-137.

参考文献

[1] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J].实用肝脏病杂志,2019,22(02):164-171.
[2] Casulleras M, Zhang IW, López-Vicario C, et al. Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure[J]. Cells,2020,9(12):2632
[3] 胡世芸,陈妍雯,潘宗琴,等.我国肝衰竭医院感染危险因素的Meta分析[J].遵义医学院学报,2014,37(05):520-528.
[4] Yang L, Wu T, Li J, et al. Bacterial Infections in Acute-on-Chronic Liver Failure[J]. Semin Liver Dis, 2018,38(2):121-133.
[5] Jin M, Khan AI. Procalcitonin: uses in the clinical laboratory for the diagnosis of sepsis[J]. Lab Med, 2010, 41(3): 173-177.
[6] 康娜玲,吴佳莉,颜燕燕等.降钙素原在非感染的终末期肝病患者中的表达水平及影响因素[J].福建医科大学学报,2018,52(06):364-368.
[7] Bellot P, Francés R, Such J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications[J]. Liver Int,2013,33(1):31-39.
[8] 徐小元,丁惠国,李文刚,等. 肝硬化腹水及相关并发症的诊疗指南[J].实用肝脏病杂志,2018,21(01):21-31.
[9] Rule JA, Hynan LS, Attar N, et al. Procalcitonin Identifies Cell Injury, Not Bacterial Infection, in Acute Liver Failure[J]. PLoS One,2015,10(9):e0138566.
[10] Lin S, Yan Y, Wu Y, et al. Procalcitonin as a biomarker for diagnose of bacterial infection in patients with acute-on-chronic liver failure[J]. Clin Res Hepatol Gastroenterol,2020,44(2):e32-e34.
[11] Chen J, Huang ZB, Li H, et al. Early Diagnostic Biomarkers of Sepsis for Patients with Acute-on-Chronic Liver Failure: A Multicenter Study[J]. Infect Dis Ther,2021,10(1):281-290.
[12] Igna R, Gîrleanu I, Cojocariu C, et al. The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure[J]. J Clin Med,2022,11(18):5410.
[13] He X, Chen L, Chen H, et al. Diagnostic Accuracy of Procalcitonin for Bacterial Infection in Liver Failure: A Meta-Analysis[J]. Bioinorg Chem Appl,2021,2021:5801139.
[14] Mallet M, Haq M, Tripon S, et al. Elevated procalcitonin is associated with bacterial infection during acute liver failure only when unrelated to acetaminophen intoxication[J]. Eur J Gastroenterol Hepatol,2017,29(7):811-816.
[15] Qu J, Feng P, Luo Y, et al. Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases[J]. Medicine (Baltimore), 2016,95(30):e4270.
[16] Garnacho-Montero J, Huici-Moreno MJ, Gutiérrez-Pizarraya A, et al. Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis[J]. Crit Care, 2014,18(3):R116.
[17] Yuan LY, Ke ZQ, Wang M, et al. Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis B[J]. Ann Lab Med,2013,33(6):449-454.
[18] Zhang X, Chen P, Gao H, et al. Bacterial infection and predictors of mortality in patients with autoimmune liver disease-associated acute-on-chronic liver failure[J]. Can J Gastroenterol Hepatol, 2018,2018:5108781.
[19] 杨凡,焦方舟,李汛,等. 血清降钙素原检测对早期诊断肝衰竭合并感染的临床意义[J].现代生物医学进展,2018,18(17):3250-3254.
[20] 梁艳华,兰剑锋,谭国玉. HBV相关慢加急性肝衰竭合并细菌感染患者AFP、PCT、CRP、IL-6的变化及临床意义[J].海南医学,2022,33(16):2056-2059.
[21] Wang X, Tang G, Liu Y, et al. The role of IL-6 in coronavirus, especially in COVID-19[J]. Front Pharmacol, 2022,13:1033674.
[22] Mayr U, Lukas M, Elnegouly M, et al. Ascitic Interleukin 6 Is Associated with Poor Outcome and Spontaneous Bacterial Peritonitis: A Validation in Critically Ill Patients with Decompensated Cirrhosis[J]. J Clin Med,2020,9(9):2865.
[23] Li L, Chen L, Lin F, et al. Study of the Expression of Inflammatory Factors IL-4, IL-6, IL-10, and IL-17 in Liver Failure Complicated by Coagulation Dysfunction and Sepsis[J]. J Inflamm Res,2021,14:1447-1453.
[24] 张国民,王鑫,韩智炜等.降钙素原、白细胞介素6、sCD14、CD64检测在肝功能衰竭患者诊治中的临床研究[J].中国现代医学杂志,2019,29(03):47-51.
[25] 雷飞飞. 降钙素原、C反应蛋白及白介素-6对慢加急性肝衰竭并发SBP的临床诊断价值探讨[D].新疆医科大学,2016.
[26] Zhou C, Zhang N, He TT, et al. High levels of serum interleukin－6 increase mortality of hepatitis B virus-associated acute -on -chronic liver failure[J]. World J Gastroenterol, 2020,26 ( 30 ) : 4479-4488.
[27] Laugerette F, Alligier M, Bastard JP, et al. Overfeeding increases postprandial endotoxemia in men: Inflammatory outcome may depend on LPS transporters LBP and sCD14[J]. Mol Nutr Food Res, 2014,58(7):1513-1518.
[28] Wang X, Li ZY, Zeng L, et al. Neutrophil CD64 expression as a diagnostic marker for Sepsis in adult patients:a meta analysis[J]. Crit Care,2015,19(1):245.
[29] Abeles RD, Taylor NJ, Vijay GK, et al. Neutrophil CD64 expression is elevated in acetaminophen-induced acute liver failure[J]. Am J Respir Crit Care Med, 2012,186(10):1058-1060.
[30] 王鑫,张国民,牛兴杰,等. 外周血NLR、nCD64在HBV相关ACLF继发感染和短期预后中的诊断及预测价值[J].肝脏,2022,27(01):72-75.
[31] 熊克宫,柯坤宇,孔金峰,等. 中性粒细胞CD64联合降钙素原对慢加急性肝衰竭合并细菌感染患者的诊断及预后评估价值[J].实用医学杂志,2019,35(18):2914-2917.
[32] Tammaro A, Derive M, Gibot S,et a1. TREM-l and its potential ligands in non-infectious diseases: from biology to clinical perspectives [J]. Pharmacol Ther,2017,177:8l-95.
[33] Yadav P, Trehanpati N, Maiwall R, et al. Soluble factors and suppressive monocytes can predict early development of sepsis in acute-on-chronic liver failure[J]. Hepatol Commun. 2022,6(8):2105-2120.
[34] Li B, Xia Y, Hu B. Infection and atherosclerosis: TLR-dependent pathways[J]. Cell Mol Life Sci, 2020,77(14):2751-2769.
[35] Engelmann C, Sheikh M, Sharma S, et al. Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure[J]. J Hepatol, 2020,73(1):102-112.
[36] 卢喜玲,刘俊平,曹永革等.重症肝病合并腹腔感染患者TLR2和TLR4 mRNA表达及其应用价值[J].中华医院感染学杂志,2020,30(20):3071-3075.
[37] 王鑫,张国民,牛兴杰等.肝衰竭继发感染患者外周血Toll样受体4及降钙素原、C反应蛋白变化情况分析[J].现代消化及介入诊疗,2019,24(10):1084-1087+1094.
[38] Buonacera A, Stancanelli B, Colaci M, et al. Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases[J]. Int J Mol Sci, 2022,23(7):3636.
[39] Asik Z. The Role of the NLR and PLR in Urinary Tract Infection[J]. Clin Lab, 2021,67(10):10.
[40] Boralkar KA, Kobayashi Y, Amsallem M, et al. Value of Neutrophil to Lymphocyte Ratio and Its Trajectory in Patients Hospitalized With Acute Heart Failure and Preserved Ejection Fraction[J]. Am J Cardiol. 2020,125(2):229-235.
[41] Sun J, Guo H, Yu X, et al. Evaluation of prognostic value of neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure or severe liver injury from chronic HBV infection[J]. Eur J Gastroenterol Hepatol, 2021,33(1S Suppl 1):e670-e680.
[42] 陈科第.肝衰竭患者中性粒细胞与淋巴细胞比值对判断细菌所致腹腔感染的临床价值[J].传染病信息,2023,36(01):38-42+64.